Publicacións en colaboración con investigadores/as de King's College London (9)

2018

  1. Increased Levels of Brain Adrenomedullin in the Neuropathology of Alzheimer’s Disease

    Molecular Neurobiology, Vol. 55, Núm. 6, pp. 5177-5183

2017

  1. Serotonin 5-HT6 Receptor Antagonists in Alzheimer’s Disease: Therapeutic Rationale and Current Development Status

    CNS Drugs, Vol. 31, Núm. 1, pp. 19-32

2015

  1. Alterations in brain leptin signalling in spite of unchanged CSF leptin levels in Alzheimer's disease

    Aging Cell, Vol. 14, Núm. 1, pp. 122-129

2014

  1. Decreased rabphilin 3A immunoreactivity in Alzheimer's disease is associated with Aβ burden

    Neurochemistry International, Vol. 64, Núm. 1, pp. 29-36

  2. Serotonergic therapies for cognitive symptoms in alzheimer's disease: Rationale and current status

    Drugs, Vol. 74, Núm. 7, pp. 729-736

2013

  1. CB2 receptor and amyloid pathology in frontal cortex of Alzheimer's disease patients

    Neurobiology of Aging, Vol. 34, Núm. 3, pp. 805-808

2010

  1. Altered NCAM expression associated with the cholinergic system in alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 20, Núm. 2, pp. 659-668

  2. Neurochemical basis for symptomatic treatment of Alzheimer's disease

    Neuropharmacology, Vol. 59, Núm. 4-5, pp. 221-229

1998

  1. Current neurotransmitter strategies in AD drug development

    PROGRESS IN ALZHEIMER'S AND PARKINSON'S DISEASES